FBLG
FBLG
NASDAQ · Biotechnology

Fibrobiologics Inc

$0.20
-0.02 (-10.64%)
Financial Highlights (FY 2025)
Revenue
4.23M
Net Income
-124,680
Gross Margin
33.2%
Profit Margin
-3.0%
Rev Growth
+15.0%
D/E Ratio
1.05
Revenue & Net Income
Margin Trends
FY 2025 FY 2024 FY 2023
Gross Margin 33.2% 33.2% 33.2%
Operating Margin -2.3% -2.6% -2.2%
Profit Margin -3.0% -2.8% -3.0%
Income Statement
FY 2025 FY 2024 FY 2023
Revenue 4.23M 4.47M 3.50M
Gross Profit 1.41M 1.49M 1.16M
Operating Income -97,781 -117,677 -76,784
Net Income -124,680 -125,666 -103,892
Gross Margin 33.2% 33.2% 33.2%
Operating Margin -2.3% -2.6% -2.2%
Profit Margin -3.0% -2.8% -3.0%
Rev Growth +15.0% +2.0% +12.9%
Balance Sheet
FY 2025 FY 2024 FY 2023
Total Debt 9.10M 8.99M 8.05M
Total Equity 8.67M 8.06M 7.41M
D/E Ratio 1.05 1.12 1.09
Cash Flow
FY 2025 FY 2024 FY 2023
EBITDA -157,557 -149,483 -127,277
Free Cash Flow -89,797 -95,523 -91,369